Bajaj, MD 5:46 – 5:56 PM Discussion 5:56 – 6:08 PM How Can We Prevent Nosocomial and MDR Infections? An Infectious Disease Physician’s Perspective Larry Baddour, MD 6:08 – 6:18 PM Discussion 6:18 – 6:30 PM Future Challenges and Development of New Strategies for Unmet Needs Patrick S. Kamath, MD 6:30 – 6:40 PM Discussion 6:40 – 6:45 PM Wrap-up SIG Program Sunday, November 3 4:45 – 6:45 PM Room 150A The Cell Biology of Hepatic Disease Sponsored by the Liver Cell Biology in Hepatic Disease and Liver Fibrosis SIGs MODERATORS: Mark A. McNiven, PhD

Natalie Torok, MD Allan W. Wolkoff, MD Natalia Nieto, PhD This special interest group program has been combined by the Hepatic Cell Biology and Mechanisms of Liver Fibrosis SIGs. The program is divided into sub-sections covering selleck basic hepatocellular processes such as membrane trafficking, cell signaling, cytoskeletal dynamics, and matrix/stromal biology. Extending from these seminal processes will be disease-oriented presentations on cholestasis, viral infection, and steatosis with a strong emphasis

Cobimetinib nmr on hepatocellular injury as it relates to liver fibrosis. The program includes state-of-the-art talks in the field and provides a unique perspective on how cellular processes are connected during liver injury. Learning Objectives: Gain a greater understanding of basic cell biological functions of hepatic cells such as protein/lipid traffic, cytoskeletal organization, cellular polarity, and receptor signaling cascades in health and disease. Pathological changes in cellular functions can translate into modulation of

trafficking, cell adhesion and matrix production leading to liver damage, cholestasis, and fibrogenic signals Understand how the central processes listed above are altered and tailored to suit the highly specialized functions of the liver including regeneration, bile formation, endocytic-based filtering of the blood, secretion of essential plasma proteins, and regulation of the extracellular matrix Identify how hepatocellular functions are usurped and modified during hepatic diseases such as liver fibrosis and cancer 4:45 – 4:47 find more PM Introduction Session I: Membrane Traffic and Signaling in Hepatic Disease 4:47 – 5:14 PM Regulation of Hepatic Steatosis and Liver Injury by Autophagy Mark J. Czaja, MD 5:14 – 5:41 PM Growth Factor Pathways in Development and Progression of Hepatocellular Carcinoma George K. Michalopoulos, MD, PhD 5:41 – 5:51 PM Break Session II: Cell Adhesion, Stromal Biology and Hepatic Fibrosis 5:51-6:18 PM Kinase Activation Pathways in Hepatic Fibrosis Vijay Shah, MD 6:18 – 6:45 PM Cellular Mechanisms of Hepatic Fibrosis Rebecca G.